Past Events

Measuring progress in neglected disease drug development

Professor Joshua Cohen, Tufts University
February 6, 2015

Cervical cancer prevention, diagnosis, and treatment: Practicing evidence-based public health policy and practice in Cameroon

Dr. Javier Gordon Ogembo, UMass Medical School
October 17, 2014

Psychosocial constructions of the human papillomavirus vaccine (HPV) amongst young women in Scotland, Spain, Bulgaria, and Serbia

Dr. Carol Gray, Edinburgh Napier University
September 26, 2014

Giving well: Charity for Global Health

Professor Patricia Illingworth, Department of Philosophy & Religion
April 4, 2014
Egan 206

The need for new antibacterials to counter multi-drug resistance

Professor James Aggen, Department of Chemistry & Chemical Biology
March 21, 2014
Egan 206

Social Change and health in Eastern Europe, with a focus on cervical cancer

Professor Irina Todorova, Department of Health Sciences
February 28, 2014

Distributing rapid diagnostic tests for malaria through the private sector in Uganda

Professor William Dickens, Department of Economics
January 31, 2014

Microfluidic technologies for global health

Professor Shashi Murthy, Department of Chemical Engineering
December 13, 2013

Researching leishmaniasis in Kenya

Professor Richard Wamai, Department of African American Studies
November 15, 2013

Treatment as prevention for HIV-Focusing on intellectual property and market dynamics

Professor Brook Baker, School of Law
October 18, 2013

Doing research for the neglected: drug discovery for the diseases of the poor

Professor Michael Pollastri, Department of Chemistry & Chemical Biology
September 20, 2013

Learn how a range of health industries will contribute to a healthier world of the future, and consider how your career will move us toward that future.

Professional Forum: Career Paths in Global Health
Boston Young Healthcare Professionals
Thursday, January 24, 2013
5:30 – 7:30 pm
Raytheon Amphitheater, Northeastern University
360 Huntington Ave, Boston, MA 02115
 
 

After the Storm: New Directions in Health Policy and Law

Friday, April 19, 2013
8:30-4:30
Raytheon Amphitheater, Northeastern University
360 Huntington Ave, Boston, MA 02115
http://www.northeastern.edu/law/academics/institutes/health-law/events/after-the-storm/
 
 

Chemical Biology and Lead Drug Discovery in the African Trypanosome

Tuesday, December 4, 2012
10 a.m.
Professor Kojo Mensa-Wilmot, Ph.D.
440 Egan at Northeastern University
College of Science Global Health Special Seminar
 

Drs. Halperin and Wamai will explore the science, practice and implementation of male circumcision and field the many questions regarding its potential as the “cutting edge” for preventing HIV infections.

For more information, click here!

Wednesday, November 28, 2012
12:00 p.m.
Professor Richard Wamai, Ph.D. with guest Professor Daniel Halperin, Ph.D
94 Cargill at Northeastern University School of Law
The Cutting Edge: Male Circumcision for HIV Prevention
HIV/AIDS Policy Grand Rounds
 
 

Multiple and Intersecting Approaches to Developing Drugs for the ‘Neglected’ Tropical Diseases (From Targets to Screens and Back Again…)

Tuesday, November 20, 2012
10 a.m.
Conor Caffrey, Ph.D.
440 Egan at Northeastern University
College of Science Global Health Special Seminar 
 
 

Mass Spectrometry Guided Medicinal Chemistry of Antimalarial and Anticancer Agents

Friday, November 16, 2012
10 a.m.
Professor Roman Manetsch, PhD
440 Egan at Northeastern University
College of Science Global Health Special Seminar
 
 

Optimizing the Response of Prevention: HIV Efficiency in Africa Project, Program on Health Policy and Law Faculty Roundtable

Monday, October 15, 2012
12:00 p.m.
Northeastern University African American Studies Professor Richard Wamai, Ph.D
Brown University Health Services Policy & Practice Professor Omar Galarraga
42 Dockser Hall at Northeastern University

Although tremendous advances have been made in our understanding and treatment of disease, major challenges remain in improving health for populations in the developing world. Complex issues such as inadequate therapies, poor infrastructure, governmental policy, and inadequate health care and education stifle progress. In the face of these multiple challenges, diseases that are endemic in developing nations are repeatedly ‘neglected’ by scientists and pharmaceutical companies based in developed nations. Of the 1,556 new drugs developed from 1975 to 2004, tropical diseases and TB accounted for only 1.3 percent of them, despite making up 12 percent of the world’s disease burden. There is hope for cures to some of the world’s neglected diseases through repurposing existing drugs and drug discovery knowledge, since many biochemical mechanisms in neglected diseases are shared with well-studied mechanisms in humans.

Find out how Northeastern is making a difference.

Miss the talk? Read some of what Professor Pollastri shared here and listen to the presentation here!

Friday, October 12, 2012
1 p.m.
Chemistry Professor Michael Pollastri, Ph.D.
Raytheon Amphitheater at Northeastern University
Addressing Neglected Tropical Diseases, College of Science Colloquium